Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

RT @PaperbirdsH: New article: Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpat…

RT @BioMedCentral: COVID-19 patients with cardiometabolic diseases show a lower risk of arterial or venous thrombotic outcomes on using dir…

RT @BioMedCentral: COVID-19 patients with cardiometabolic diseases show a lower risk of arterial or venous thrombotic outcomes on using dir…

COVID-19 patients with cardiometabolic diseases show a lower risk of arterial or venous thrombotic outcomes on using direct-acting oral anticoagulant therapy instead of Vitamin K antagonist therapy, reports a study published in Cardiovascular Diabetology.